Tarun Kewalramani to Disease Progression
This is a "connection" page, showing publications Tarun Kewalramani has written about Disease Progression.
Connection Strength
0.130
-
Kewalramani T, Zelenetz AD, Teruya-Feldstein J, Hamlin P, Yahalom J, Horwitz S, Nimer SD, Moskowitz CH. Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma. Br J Haematol. 2006 Jul; 134(2):202-7.
Score: 0.046
-
Kewalramani T, Nimer SD, Zelenetz AD, Malhotra S, Qin J, Yahalom J, Moskowitz CH. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma. Bone Marrow Transplant. 2003 Oct; 32(7):673-9.
Score: 0.038
-
Kewalramani T, Moskowitz CH. Upfront transplantation for poor-risk aggressive non-Hodgkin lymphoma and Hodgkin's disease: who benefits? Curr Oncol Rep. 2001 May; 3(3):271-8.
Score: 0.032
-
Moskowitz AJ, Perales MA, Kewalramani T, Yahalom J, Castro-Malaspina H, Zhang Z, Vanak J, Zelenetz AD, Moskowitz CH. Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma. Br J Haematol. 2009 Jul; 146(2):158-63.
Score: 0.014